Soleno Therapeutics, Inc. held its 2023 Annual Meeting of Stockholders, where stockholders voted on various items including the election of directors, ratification of the appointment of the independent registered public accounting firm, approval of executive compensation, approval of the frequency of stockholder votes on executive compensation, approval of an equity incentive plan, and approval of a private placement.